Background Malaria was eliminated from Southern and Southeastern Brazil over 50 years ago. However, an increasing number of autochthonous episodes attributed to Plasmodium vivax have been recently reported in the Atlantic forest region of Rio de Janeiro State. As P. vivax-like non-human primate malaria parasite species Plasmodium simium is locally enzootic, we performed a molecular epidemiological investigation in order to determine whether zoonotic malaria transmission is occurring.
Introduction
Zoonotic malaria occurs when humans become infected with malaria parasite species that more commonly infect non-human primates. Species such as Plasmodium knowlesi and Plasmodium cynomolgi, both parasites of macaque monkeys, can infect humans via the bites of infected mosquitoes under natural and experimental conditions. Although no transmission from humans to mosquitoes has yet been documented in the field, P. knowlesi has recently been shown to be responsible for many cases of human malaria in Southeast Asia, mostly affecting individuals living or working in close contact with forests. 1 Zoonotic malaria poses a unique problem for malaria control efforts and complicates the drive towards eventual elimination of the disease.
Once prevalent throughout the country, malaria transmission in Brazil currently occurs almost entirely within the northern Amazon region of the country. However, there are a consistent number of autochthonous cases reported in southern and southeastern Brazil; regions from where human malaria was eliminated 50 years ago. 2 Most of these episodes are attributed to P. vivax, predominantly occur in areas of dense Atlantic forest vegetation, and mainly affect non-resident visitors. In most outbreaks, there is no identifiable index case that could have introduced the parasite from a malaria endemic region. 3 It has been hypothesized that autochthonous "P. vivax" malaria in the Atlantic forest could be the result of infection by malaria parasites species that commonly infect non-human primates 4 . Deane 5 proposed that monkeys could serve as reservoirs of Plasmodium that could infect humans. In the forests of continental America, two species of Plasmodium infecting non-human primates have been described: Plasmodium simium Fonseca, 1951 and Plasmodium brasilianum Gonder & von Berenberg-Gossler, 1908. These are similar at the morphological, genetic, and immunological levels to P. vivax and P. malariae, respectively. [5] [6] [7] [8] [9] In the state of Rio de Janeiro, located along the coast in the Southeast region of Brazil, sporadic autochthonous malaria cases have been reported from the Atlantic forest area since 1993. Between 2006 and 2014, sixty-one autochthonous malaria cases were reported in Rio de Janeiro, an average of 6·8 cases per year, with an unexpectedly high incidence in 2015 (n=33) and 2016 (n=16).
Here we describe the parasitological and molecular analyses of parasites causing autochthonous human malaria in the Atlantic forest region of Rio de Janeiro in 2015 and 2016 with the aim of determining whether zoonotic malaria transmission occurs there.
Methods

Study area and population
Rio de Janeiro State is located in the Southeast region of Brazil. It is essentially a mosaic of urban areas with high population densities, mostly in the coastal lowlands, and mountain areas covered by the Atlantic forest containing small cities and settlements scattered in the valleys. 10 Localities where malaria cases have been reported are situated in valleys between 280 and 1300 meters above sea level. 11 Detailed descriptions of the environmental characteristics of the Atlantic forest are published elsewhere. 
Ethical clearance
The INI-Fiocruz Ethical Committee in Research approved the study (N. 0062.0.009.000-11). All participants provided informed consent.
Study design
This is a descriptive study with parasitological and molecular characterization of the autochthonous malaria cases acquired in the Rio de Janeiro Atlantic forest in 2015 and 2016. An epidemiological investigation was performed to characterize the likely location of infection for classifying each episode as autochthonous.
Patient Procedures
Individuals were recruited upon presentation of signs and/or symptoms suggestive of malaria, a history of travel to or habitation in areas within the Rio de Janeiro Atlantic forest and a positive test by blood smear and/or PCR. The following exclusion criteria were applied: malaria prophylaxis, blood transfusion or tissue/organ transplantation, use of intravenous drugs, needle stick injury, residence or recreation near ports or airports or travel to known malaria endemic areas in the preceding year. Following informed consent, venous blood was drawn for clinical laboratory analyses and molecular studies. Additional tests such as blood culture and viral serology were performed at the attending physician´s discretion.
Diagnosis by microscopy
Giemsa-stained thin and thick blood smears were examined by bright-field microscopy, using a 100x/1·3 NA oil immersion objective lens for species identification and parasite density estimation. 12 Blood films were examined for a minimum of 100 fields in the case of the presence of malaria parasites and 500 fields when no parasites could be detected. Parasite numbers were recorded per 200 white blood cells (WBC) or 500 WBCs in the case of low parasitemia. To estimate parasite density per μL of blood, a standard mean WBC count of 6,000/ μL blood was assumed. All slides were subsequently examined by an independent malaria microscopist qualified by PAHO/WHO malaria accreditation course.
DNA extraction and PCR
DNA was extracted from whole blood with the QIAamp midi kit®, according to the manufacturer's protocol (Qiagen). DNA samples were tested for P. vivax by conventional PCR 13 and by real time PCR, both using the cysteine-proteinase gene as a target (GenBank number L26362). For real time PCR, 2·5 μl of DNA were added to a 47·5 μL mixture containing the 1× TaqMan® Universal PCR Master Mix (Applied Biosystems), 300 nM of each primer Pv1 (5′ATCAACGAGCAGATGGAGAAATATA3′) and Pv5 (5′GCTCTCGAAATC TTTCTTCGA3′), and 150 nM of PVIV probe (5′ FAM™ AACTTCAAAATGAATTATCTC MGB™ NFQ 3′) (Applied Biosystems). Amplification conditions involved two holds (50 °C/2 minutes and 95 °C/10 minutes) followed by 40 cycles of amplification (95 °C/15 seconds and 60 °C/1 minutes). The real-time PCR was run at least in duplicate on the ABI PRISM Sequence Detection System 7500 (Applied Biosystems). The results were analyzed using the real-time software (ABI Prism 7500 software v. 1.1 RQ study). TaqMan® RNaseP Control 20x (Applied Biosystems, California, EUA) was used as endogenous reaction control. To avoid DNA contamination, separated workstations for mix preparation and DNA extraction were utilized and DNA Away® was applied for surface decontamination. Positive (DNA extracted from blood from patients with known P. vivax infection) and negative (no DNA and DNA extracted from individuals who have never traveled to malaria-endemic areas) controls were used in each round of amplification.
Non-human primate samples
DNA was extracted from samples obtained from four howler monkeys from distinct sites and times in Southeastern Brazil. DNA extracted from the spleen and liver of one brown howler monkey (Alouatta clamitans) found dead in Guapimirim (one of the municipalities where human malaria occurs in the Rio de Janeiro Atlantic forest), was used for Plasmodium detection by nested-PCR.
14 Samples from both organs were positive for P. vivax/P.simium DNA. 15 DNA was also extracted from blood of two A. clamitans, one of them captured in 2016 at Vale das Princesas, Miguel Pereira (a site where human cases have also been reported in the Rio de Janeiro state), which tested positive for both P. vivax/P. simium and P. brasilianum/malariae, and one other from Macaé (another locality with human cases), also positive for P. vivax/P. simium. In addition, a P. simium reference sample (ATCC ® 30130™), derived from a howler monkey (Alouatta fusca) captured in São Paulo, Southeast Brazil, in 1966, was also used (https://www.atcc.org/~/ps/30130.ashx).
DNA was extracted from a sample acquired from ATCC in 1994 and kept frozen in N2 until use. The DNA extracted from all these four monkey samples was further submitted to mitochondrial genome analysis.
Molecular phylogenetic analysis of P. simium infections
Thirty-three samples were obtained from autochthonous human cases, two from monkeys of Rio de Janeiro Atlantic forest transmission sites and one ATCC P. simium reference sample and were subjected to malaria parasite mitochondrial genome sequencing.
Whole mitochondrial genome sequencing was performed on a subset of the human infections (three cases: AF1, AF2, and AF3) and the ATCC reference sample, following the methodology described in and compared with 794 P. vivax mitochondrial genome sequences and three sequences of P. simium (accession numbers AY800110, NC_007233 and AY722798, all of which have identical sequences) deposited in Genbank. [16] [17] [18] [19] [20] [21] [22] Using these sequences, a median-joining haplotype network was produced with NETWORK 4.5.0 (Fluxus technology Ltd. 2006), as previously described. 23 The mitochondrial genome of the other thirty samples was partially sequenced to distinguish P. simium samples from P. vivax. Plasmodium simium differs from the most closely related P. vivax isolate at two unique single nucleotide polymorphisms (SNPs) in the mitochondrial genome, at positions 3535 (T−>C) and 3869 (A−>G), numbered according to the nucleotide sequences deposited by . 23 These two SNPs are close together, and can be PCR amplified and sequenced with a single set of primers, or with a nested PCR if DNA concentrations are low. Primer pairs for the outer PCR are Outer PCR Primers: PsimOUTF 5´CAGGTGGTGTTTTAATGTTATTATCAG3´ and PsimOUTR 5´GCATAGGTAAGAATGTTAATACAACTCC3´. For the inner PCR, the primers are PsimINF 5´GCT GGAGATCCTATTTTATATCAAC3´ and PsimINR 5´ATGTAAACAATCCAATAATTGCACC3´.
RESULTS
In 2015, 33 autochthonous malaria cases occurred in the Rio de Janeiro state, 25 (76%) of them processed at the DFA outpatient clinic of Fiocruz. In 2016 (up to October 31 st ), 16 autochthonous malaria cases occurred in Rio de Janeiro, 14 (87·5%) seen at the DFA-Fiocruz, totaling 39 (79·6%) out of the 49 cases reported in the state. In all cases, transmission occurred in low-population density non-urban sites located in Atlantic forest areas (Figure 1) . It was the first malaria episode for all patients, and none presented clinical or laboratory complications associated with malaria. In 37 cases the diagnosis of P. vivax was made by microscopy. The highest parasitaemia was 3,000 parasites per μL of blood and, in more than 63% of the cases, it was lower than 500 parasites per μL. Two patients were negative for the presence of parasites by microscopy. A PCR assay for P. vivax species detection, but which does not discriminate between P. vivax and P. simium, suggested the presence of P. vivax in 38 (out of the 39) patients.
Morphological characteristics
When compared with P. vivax from the malaria endemic Amazonian regions, parasites from the Atlantic forest diagnosed as P. vivax were morphologically different (Suppl. Table 1 ). Trophozoites are pleomorphic but less amoeboid than those observed in P. vivax. They had a large mass of chromatin and a more compact cytoplasm with malaria pigment. Usually stippling was mostly observed in infected cells with late developmental forms, but erythrocytes containing early trophoizoites were also frequently dotted (Figure 2, A-F) . In addition, developing schizonts contained fewer merozoites than in P. vivax (Figure 2 Non-infected erythrocytes showed marked anisocytosis and poikilocytosis. The latter was represented mainly by acanthocytes, dacrocytes and spherocytes, which occurred together on the same preparations.
Molecular Characterization
Twenty samples from 25 cases occurring in 2015 and 13 samples from the 14 cases in 2016 were analyzed by molecular tests in view of the diagnosis of the Plasmodium sp. Because of the low amount and bad quality of extracted DNA, the full-length mitochondrial genome sequence was obtained for only four samples (three human samples and one P. simium reference strain).
Analysis of this mitochondrial genome sequence revealed that all four samples shared identical sequences, and these were identical to the mitochondrial genome sequence of P. simium available at genbank, which differs from the most closely related isolates of P. vivax by two unique P. simium-specific SNPs. Analysis of 794 full-length mitochondrial genome sequences from globally acquired P. vivax samples [1] [2] [3] [4] [5] [6] [7] confirmed that these SNPs were unique to P. simium. A haplotype network tree ( Figure 3 ) was constructed using these sequences, and clearly shows that P. simium is most closely related to the P. vivax parasites of man isolated from South America.
Characterization of further infections using informative mtDNA SNPs
Of 33 samples species-typed based on the two informative SNPs that differentiate P. vivax from P. simium, we were able to diagnose an infection of P. simium in 28 of them (Table 1) . We were unable to achieve PCR amplification for the remaining five samples, due to technical constraints. The same informative SNPs were found in Plasmodium simium infecting three local howler monkeys, MB CPRJ, RJ30 and RJ59 (Table 1) .
Discussion
The New World non-human primate tertian malaria parasite P. simium was first identified by Fonseca (1951) in a monkey from the state of São Paulo, Brazil. It appears to be restricted to the Atlantic forest in southern and southeastern Brazil. 4, 5, [24] [25] [26] Here, we show that P. simium is infecting and causing disease in humans. Fonseca (1951) 27 , Garnham (1966) 28 and Deane highlighted the morphological differences between P. vivax and P. simium; the trophozoites of the latter being less amoeboid and with coarser and more precocious and very prominent Schuffner's dots than P. vivax. Garnham (1966) 28 pointed that the detection of stippling in P. simium early parasitized cells depends on the staining procedures. These morphological characteristics of P. simium are consistent with those described here for the infections of humans from the Atlantic forest (Figure 2 , Suppl Table) .
Despite initial diagnoses of P. vivax for these infections, molecular evidence has revealed that these parasites are P. simium. This misdiagnosis of a zoonotic non-human primate malaria parasite as a human parasite species has precedent and parallels the discovery of the large focus of P. knowlesi in Borneo, which was initially attributed to P. malariae on the basis of morphological characteristics. 29 Notwithstanding the apparent genetic similarity of P. simium to P. vivax, attempts at inducing infections of P. simium in humans under laboratory conditions have been unsuccessful. 6 In 1966, however, Deane et al described the infection of a man with a P. vivax-like parasite that they considered to be P. simium, based on morphological characteristics of the parasite and on the fact that infection had occurred in a fore st reserve outside São Paulo, where P. simium was known to be transmitted. 30 This remains the only previous case report of a possible human infection with P. simium.
We show here that P. simium can and does infect humans under natural conditions and can cause outbreaks of zoonotic disease in the Atlantic forest region in Rio de Janeiro. This situation has immediate implications for public health in this region, and further and more profound consequences for the control and eventual elimination of malaria in Brazil.
Patients who were naturally infected with P. simium reported clinical symptoms congruent to those of vivax malaria, and responded successfully to chloroquine and primaquine, with no deaths reported. It is not currently known whether P. simium is capable of producing hypnozoites in humans and, thus, relapses, as does P. vivax. However, one patient (from February 2015, AF3), who were treated solely with chloroquine due to G6PD deficiency, and one other (January 2016, AF21) who discontinued primaquine treatment due to adverse events, have not presented any relapse to date (March 2017), suggesting that hypnozoites were not formed. Further followup of this cohort is required to monitor potential relapse in these patients.
In summary, we report here that the malaria outbreaks in 2015, and in 2016 in the Atlantic forest of southeastern Brazil were caused by P. simium, previously considered to be a monkey-specific species of malaria parasite, related to but distinct from P. vivax, and which has never conclusively been shown to infect humans before. Such zoonotic transmission of malaria from a monkey reservoir to man has immediate consequences for public health in this region, and, furthermore, for future attempts to control and eventually eliminate malaria in Brazil. Thorough screening of the local non-human primate and anopheline mosquito populations in this area is required to evaluate the extent of this newly recognized zoonotic threat to public health. This unequivocal demonstration of zoonotic transmission, 50 years after the only previous report of P. simium in man, leads to the possibility that this parasite has always infected humans in this region, but that it has been consistently misdiagnosed as P. vivax due to a lack of molecular typing techniques. Alternatively, it may be the case that P. simium has only recently acquired the ability to frequently infect humans. This latter scenario has extremely important implications in terms of parasite/host relationships and evolution. Table 1 
